- Home
- KO vs ABBV Comparison
KO vs ABBV Comparison
Compare KO & ABBV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KO
- ABBV
- Stock Information
- Founded
- KO 1886
- ABBV 2012
- Country
- KO United States
- ABBV United States
- Employees
- KO N/A
- ABBV N/A
- Industry
- KO Beverages (Production/Distribution)
- ABBV Biotechnology: Pharmaceutical Preparations
- Sector
- KO Consumer Staples
- ABBV Health Care
- Exchange
- KO Nasdaq
- ABBV Nasdaq
- Market Cap
- KO 309.0B
- ABBV 329.1B
- IPO Year
- KO 1919
- ABBV N/A
- Fundamental
- Price
- KO $71.20
- ABBV $185.56
- Analyst Decision
- KO Strong Buy
- ABBV Buy
- Analyst Count
- KO 17
- ABBV 23
- Target Price
- KO $75.41
- ABBV $212.00
- AVG Volume (30 Days)
- KO 16.3M
- ABBV 8.0M
- Earning Date
- KO 04-29-2025
- ABBV 04-25-2025
- Dividend Yield
- KO 2.87%
- ABBV 3.54%
- EPS Growth
- KO 0.01
- ABBV N/A
- EPS
- KO 2.49
- ABBV 2.34
- Revenue
- KO $46,890,000,000.00
- ABBV $57,367,000,000.00
- Revenue This Year
- KO $5.09
- ABBV $7.79
- Revenue Next Year
- KO $5.15
- ABBV $7.92
- P/E Ratio
- KO $28.59
- ABBV $79.31
- Revenue Growth
- KO 1.77
- ABBV 5.45
- 52 Week Low
- KO $60.62
- ABBV $153.58
- 52 Week High
- KO $74.38
- ABBV $218.66
- Technical
- Relative Strength Index (RSI)
- KO 48.04
- ABBV 46.05
- Support Level
- KO $71.01
- ABBV $185.74
- Resistance Level
- KO $72.69
- ABBV $198.98
- Average True Range (ATR)
- KO 1.30
- ABBV 5.34
- MACD
- KO -0.18
- ABBV 1.20
- Stochastic Oscillator
- KO 22.44
- ABBV 55.90
About KO Coca-Cola Company (The)
Founded in 1886, Atlanta-headquartered Coca-Cola is the world's largest nonalcoholic beverage company, with a strong portfolio of 200 brands covering key categories including carbonated soft drinks, water, sports, energy, juice, and coffee. Together with bottlers and distribution partners, the company sells finished beverage products bearing Coca-Cola and licensed brands through retailers and food-service locations in more than 200 countries and regions globally. Coca-Cola generates around two thirds of its total revenue overseas, with a significant portion from emerging economies in Latin America and Asia-Pacific.
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).